The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.

Antioxidants & Redox Signaling
Marcus J CalkinsJeffrey A Johnson

Abstract

Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor known to induce expression of a variety of cytoprotective and detoxification genes. Several of the genes commonly regulated by Nrf2 have been implicated in protection from neurodegenerative conditions. Work from several laboratories has uncovered the potential for Nrf2-mediated transcription to protect from neurodegeneration resulting from mechanisms involving oxidative stress. For this reason, Nrf2 may be considered a therapeutic target for conditions that are known to involve free radical damage. Because common mechanisms of neurodegeneration, such as mitochondrial dysfunction and build-up of reactive oxygen species, are currently being uncovered, targeting Nrf2 may be valuable in combating conditions with variable causes and etiologies. Most effectively to target this protein in neurodegenerative conditions, a description of the involvement of Nrf2 and potential for neuroprotection must come from laboratory models. Herein, we review the current literature that suggests that Nrf2 may be a valuable therapeutic target for neurodegenerative disease, as well as experiments that illustrate potential mechanisms of protection.

References

Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M B Spina, G Cohen
Apr 1, 1972·Journal of the American Geriatrics Society·D Harman
Jan 1, 1995·Life Sciences·A C Bowling, M F Beal
Jan 17, 1995·Biochemical and Biophysical Research Communications·Y ZhangP Talalay
Sep 15, 1999·Genes & Development·K Itoh, S Y Sokol
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jed W FaheyAlain Lozniewski
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Nov 21, 2002·The Journal of Biological Chemistry·Daniel StewartJawed Alam
Nov 28, 2002·American Journal of Physiology. Renal Physiology·Jawed AlamKarl A Nath
Dec 4, 2002·Toxicology and Applied Pharmacology·Matthew J PickloM Diana Neely
Mar 26, 2003·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Ken ItohMasayuki Yamamoto
Mar 27, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Laurie M Zipper, R Timothy Mulcahy
Jul 1, 1956·Journal of Gerontology·D HARMAN
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Xavier HaristoyAlain Lozniewski
Jun 3, 2004·Physiological Genomics·Jiang LiJeffrey A Johnson
Jun 9, 2004·Free Radical Biology & Medicine·Chi Chen, A-N Tony Kong
Aug 10, 2004·Nature Medicine·Julie K Andersen
Nov 3, 2004·The Journal of Clinical Investigation·Tirumalai RangasamyShyam Biswal
Nov 5, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jiang LiJeffrey Johnson
Dec 2, 2004·Brain Research. Brain Research Reviews·Luis H BarbeitoJoseph S Beckman
Dec 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Marcus J CalkinsJeffrey A Johnson
Jan 20, 2005·Molecular and Cellular Biology·Ruben N KarapetianAndrey B Vartapetian
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Apr 21, 2005·The Journal of Biological Chemistry·Andy Y ShihTimothy H Murphy
Apr 28, 2005·Planta medica·Xavier HaristoyAlain Lozniewski
Jun 25, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rebekah J JakelJeffrey A Johnson
Jun 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jong-Min LeeJeffrey A Johnson
Sep 17, 2005·Nature Reviews. Molecular Cell Biology·Christopher A Ross, Michelle A Poirier
Nov 4, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andy Y ShihTimothy H Murphy
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·T SatohS A Lipton
Jun 30, 2006·Journal of Neurochemistry·Barry Halliwell
Sep 9, 2006·Neurotoxicology·Neal C BurtonTomás R Guilarte
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal

❮ Previous
Next ❯

Citations

Jan 18, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·David J GraberBrent T Harris
Sep 21, 2011·Journal of Molecular Neuroscience : MN·Jon DangChristoph Jan Wruck
Mar 1, 2012·Cell Stress & Chaperones·Mohammad MohammadzadehMehryar Habibi Roudkenar
Jul 8, 2011·Neurotoxicity Research·Li Rebekah Feng, Kathleen A Maguire-Zeiss
Jun 6, 2009·Expert Reviews in Molecular Medicine·Marcelo R Vargas, Jeffrey A Johnson
Jul 20, 2012·Nature Reviews. Cancer·Michael B Sporn, Karen T Liby
Aug 22, 2008·Antioxidants & Redox Signaling·Daniel A Linseman
Jul 25, 2009·Antioxidants & Redox Signaling·Bobby Thomas
May 15, 2012·Nucleic Acids Research·Brian N ChorleyDouglas A Bell
Mar 18, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Alison I Bernstein, Gary W Miller
Mar 10, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Marcus J CalkinsJeffrey A Johnson
Apr 6, 2013·Exercise and Sport Sciences Reviews·Danielle J ReulandKaryn L Hamilton
Nov 26, 2010·Current Opinion in Clinical Nutrition and Metabolic Care·Gerasimos P SykiotisDirk Bohmann
Feb 6, 2013·Biochemistry. Biokhimii︠a︡·N K ZenkovV O Tkachev
Sep 10, 2011·Oxidative Medicine and Cellular Longevity·Karen F S BellGiles E Hardingham
Aug 20, 2011·Stroke; a Journal of Cerebral Circulation·Bing WangSylvain Doré
Apr 6, 2011·Blood·Elizabeth R Macari, Christopher H Lowrey
Oct 29, 2013·Journal of Neuroinflammation·Romina MaccoDaniele Zacchetti
Aug 3, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christine M LaPash DanielsAlbee Messing
Jun 14, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Carlamaria ZojaGiuseppe Remuzzi
May 28, 2013·Oxidative Medicine and Cellular Longevity·Dionysios V ChartoumpekisIoannis G Habeos
Apr 10, 2014·International Journal of Molecular Sciences·Barbara CarlettiFiorella Piemonte
Dec 24, 2013·Antioxidants & Redox Signaling·Vitaliy O Kaminskyy, Boris Zhivotovsky
Feb 1, 2013·Current Diabetes Reviews·Dionysios V Chartoumpekis, Thomas W Kensler
Mar 6, 2013·Journal of Medicinal Chemistry·Paul C TrippierRichard B Silverman
Nov 14, 2013·The International Journal of Neuroscience·Ying YangLei Zhang
Jun 18, 2009·Expert Opinion on Therapeutic Targets·Jinqing LiTaixing Cui
Jun 20, 2015·International Journal of Molecular Sciences·Qin WangYang Mao-Draayer

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Pei-Chun ChenJeffrey A Johnson
Journal of Neuropathology and Experimental Neurology
Chenere P RamseyKelly L Jordan-Sciutto
Proceedings of the National Academy of Sciences of the United States of America
Marcus J CalkinsJeffrey A Johnson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Marcelo R VargasJeffrey A Johnson
Current Drug Targets. CNS and Neurological Disorders
Freek L van Muiswinkel, H Bea Kuiperij
© 2022 Meta ULC. All rights reserved